Cargando…

The ovarian reserve as target of insulin/IGF and ROS in metabolic disorder-dependent ovarian dysfunctions

It is known for a long time that metabolic disorders can cause ovarian dysfunctions and affect a woman’s fertility either by direct targeting follicular cells and/or the oocytes or by indirect interference with the pituitary-hypothalamic axis, resulting in dysfunctional oogenesis. Such disorders may...

Descripción completa

Detalles Bibliográficos
Autores principales: Dri, Maria, Klinger, Francesca Gioia, De Felici, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801032/
https://www.ncbi.nlm.nih.gov/pubmed/35118400
http://dx.doi.org/10.1530/RAF-21-0038
_version_ 1784642366628429824
author Dri, Maria
Klinger, Francesca Gioia
De Felici, Massimo
author_facet Dri, Maria
Klinger, Francesca Gioia
De Felici, Massimo
author_sort Dri, Maria
collection PubMed
description It is known for a long time that metabolic disorders can cause ovarian dysfunctions and affect a woman’s fertility either by direct targeting follicular cells and/or the oocytes or by indirect interference with the pituitary-hypothalamic axis, resulting in dysfunctional oogenesis. Such disorders may also influence the efficiency of the embryo implantation and the quality of the embryo with permanent effects on the fertility and health of the offspring. Thanks to the expanding knowledge on the molecular mechanisms governing oogenesis and folliculogenesis in mammals, we are beginning to understand how such disorders can negatively affect this process and consequently fertility in women. In the present review, we point out and discuss how the disturbance of insulin/IGF-dependent signalling and increased reactive oxygen species (ROS) level in the ovary typically associated to metabolic disorders such as type II diabetes and obesity can dysregulate the dynamics of the ovarian reserve and/or impair the survival and competence of the oocytes. LAY SUMMARY: In women, a progressive decline and depletion of the primary ovary reserve, which represents the reserve of immature eggs, are a challenging condition in the field of reproductive medicine. This decline, occurring physiological with age, is the main determinant of the age at the onset of menopause. Concomitant with the reduction in their number, the quality of the eggs also decreases with age. Metabolic disorders such as diabetes and obesity can cause ovarian dysfunctions and affect a woman’s fertility mainly by direct targeting the egg stockpile or by indirect interference with the production of reproductive hormones. Here, we report up-to-date data and discuss results about how disturbance of insulin-dependent signalling and increased oxidative stress in the ovary, usually associated to metabolic disorders, can dysregulate the dynamics of the primary ovary reserve and/or impair the survival and quality of the eggs.
format Online
Article
Text
id pubmed-8801032
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-88010322022-02-02 The ovarian reserve as target of insulin/IGF and ROS in metabolic disorder-dependent ovarian dysfunctions Dri, Maria Klinger, Francesca Gioia De Felici, Massimo Reprod Fertil Review It is known for a long time that metabolic disorders can cause ovarian dysfunctions and affect a woman’s fertility either by direct targeting follicular cells and/or the oocytes or by indirect interference with the pituitary-hypothalamic axis, resulting in dysfunctional oogenesis. Such disorders may also influence the efficiency of the embryo implantation and the quality of the embryo with permanent effects on the fertility and health of the offspring. Thanks to the expanding knowledge on the molecular mechanisms governing oogenesis and folliculogenesis in mammals, we are beginning to understand how such disorders can negatively affect this process and consequently fertility in women. In the present review, we point out and discuss how the disturbance of insulin/IGF-dependent signalling and increased reactive oxygen species (ROS) level in the ovary typically associated to metabolic disorders such as type II diabetes and obesity can dysregulate the dynamics of the ovarian reserve and/or impair the survival and competence of the oocytes. LAY SUMMARY: In women, a progressive decline and depletion of the primary ovary reserve, which represents the reserve of immature eggs, are a challenging condition in the field of reproductive medicine. This decline, occurring physiological with age, is the main determinant of the age at the onset of menopause. Concomitant with the reduction in their number, the quality of the eggs also decreases with age. Metabolic disorders such as diabetes and obesity can cause ovarian dysfunctions and affect a woman’s fertility mainly by direct targeting the egg stockpile or by indirect interference with the production of reproductive hormones. Here, we report up-to-date data and discuss results about how disturbance of insulin-dependent signalling and increased oxidative stress in the ovary, usually associated to metabolic disorders, can dysregulate the dynamics of the primary ovary reserve and/or impair the survival and quality of the eggs. Bioscientifica Ltd 2021-08-17 /pmc/articles/PMC8801032/ /pubmed/35118400 http://dx.doi.org/10.1530/RAF-21-0038 Text en © The authors https://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Review
Dri, Maria
Klinger, Francesca Gioia
De Felici, Massimo
The ovarian reserve as target of insulin/IGF and ROS in metabolic disorder-dependent ovarian dysfunctions
title The ovarian reserve as target of insulin/IGF and ROS in metabolic disorder-dependent ovarian dysfunctions
title_full The ovarian reserve as target of insulin/IGF and ROS in metabolic disorder-dependent ovarian dysfunctions
title_fullStr The ovarian reserve as target of insulin/IGF and ROS in metabolic disorder-dependent ovarian dysfunctions
title_full_unstemmed The ovarian reserve as target of insulin/IGF and ROS in metabolic disorder-dependent ovarian dysfunctions
title_short The ovarian reserve as target of insulin/IGF and ROS in metabolic disorder-dependent ovarian dysfunctions
title_sort ovarian reserve as target of insulin/igf and ros in metabolic disorder-dependent ovarian dysfunctions
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801032/
https://www.ncbi.nlm.nih.gov/pubmed/35118400
http://dx.doi.org/10.1530/RAF-21-0038
work_keys_str_mv AT drimaria theovarianreserveastargetofinsulinigfandrosinmetabolicdisorderdependentovariandysfunctions
AT klingerfrancescagioia theovarianreserveastargetofinsulinigfandrosinmetabolicdisorderdependentovariandysfunctions
AT defelicimassimo theovarianreserveastargetofinsulinigfandrosinmetabolicdisorderdependentovariandysfunctions
AT drimaria ovarianreserveastargetofinsulinigfandrosinmetabolicdisorderdependentovariandysfunctions
AT klingerfrancescagioia ovarianreserveastargetofinsulinigfandrosinmetabolicdisorderdependentovariandysfunctions
AT defelicimassimo ovarianreserveastargetofinsulinigfandrosinmetabolicdisorderdependentovariandysfunctions